These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 9632036

  • 1. A double-blind, placebo-controlled trial of nefazodone in the treatment of patients hospitalized for major depression.
    Feighner J, Targum SD, Bennett ME, Roberts DL, Kensler TT, D'Amico MF, Hardy SA.
    J Clin Psychiatry; 1998 May; 59(5):246-53. PubMed ID: 9632036
    [Abstract] [Full Text] [Related]

  • 2. Responders to antidepressant drug treatment: a study comparing nefazodone, imipramine, and placebo in patients with major depression.
    Cohn CK, Robinson DS, Roberts DL, Schwiderski UE, O'Brien K, Ieni JR.
    J Clin Psychiatry; 1996 May; 57 Suppl 2():15-8. PubMed ID: 8626358
    [Abstract] [Full Text] [Related]

  • 3. Response of anxiety and agitation symptoms during nefazodone treatment of major depression.
    Fawcett J, Marcus RN, Anton SF, O'Brien K, Schwiderski U.
    J Clin Psychiatry; 1995 May; 56 Suppl 6():37-42. PubMed ID: 7649972
    [Abstract] [Full Text] [Related]

  • 4. A comparison of nefazodone and fluoxetine on mood and on objective, subjective, and clinician-rated measures of sleep in depressed patients: a double-blind, 8-week clinical trial.
    Gillin JC, Rapaport M, Erman MK, Winokur A, Albala BJ.
    J Clin Psychiatry; 1997 May; 58(5):185-92. PubMed ID: 9184611
    [Abstract] [Full Text] [Related]

  • 5. Antidepressant efficacy in HIV-seropositive outpatients with major depressive disorder: an open trial of nefazodone.
    Elliott AJ, Russo J, Bergam K, Claypoole K, Uldall KK, Roy-Byrne PP.
    J Clin Psychiatry; 1999 Apr; 60(4):226-31. PubMed ID: 10221282
    [Abstract] [Full Text] [Related]

  • 6. A double-blind comparison of nefazodone, imipramine, and placebo in major depression.
    Fontaine R, Ontiveros A, Elie R, Kensler TT, Roberts DL, Kaplita S, Ecker JA, Faludi G.
    J Clin Psychiatry; 1994 Jun; 55(6):234-41. PubMed ID: 8071277
    [Abstract] [Full Text] [Related]

  • 7. Nefazodone in the treatment of elderly patients with depressive disorders: a prospective, observational study.
    Saiz-Ruiz J, Ibañez A, Díaz-Marsá M, Arias F, Carrasco JL, Huertas D, Martín-Carrasco M, Moreno I, Rico-Villademoros F.
    CNS Drugs; 2002 Jun; 16(9):635-43. PubMed ID: 12153334
    [Abstract] [Full Text] [Related]

  • 8. An open-label trial of nefazodone in high comorbidity panic disorder.
    DeMartinis NA, Schweizer E, Rickels K.
    J Clin Psychiatry; 1996 Jun; 57(6):245-8. PubMed ID: 8666561
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and tolerability of once-daily venlafaxine extended release (XR) in outpatients with major depression. The Venlafaxine XR 209 Study Group.
    Thase ME.
    J Clin Psychiatry; 1997 Sep; 58(9):393-8. PubMed ID: 9378690
    [Abstract] [Full Text] [Related]

  • 10. Nefazodone in the treatment of severe, melancholic, and recurrent depression.
    Marcus RN, Mendels J.
    J Clin Psychiatry; 1996 Sep; 57 Suppl 2():19-23. PubMed ID: 8626359
    [Abstract] [Full Text] [Related]

  • 11. A multicenter double-blind comparison of nefazodone and paroxetine in the treatment of outpatients with moderate-to-severe depression.
    Baldwin DS, Hawley CJ, Abed RT, Maragakis BP, Cox J, Buckingham SA, Pover GH, Ascher A.
    J Clin Psychiatry; 1996 Sep; 57 Suppl 2():46-52. PubMed ID: 8626363
    [Abstract] [Full Text] [Related]

  • 12. Reemergence of sexual dysfunction in patients with major depressive disorder: double-blind comparison of nefazodone and sertraline.
    Ferguson JM, Shrivastava RK, Stahl SM, Hartford JT, Borian F, Ieni J, McQuade RD, Jody D.
    J Clin Psychiatry; 2001 Jan; 62(1):24-9. PubMed ID: 11235924
    [Abstract] [Full Text] [Related]

  • 13. Which depressed patients respond to nefazodone and when?
    Trivedi MH, Rush AJ, Pan JY, Carmody TJ.
    J Clin Psychiatry; 2001 Mar; 62(3):158-63. PubMed ID: 11305700
    [Abstract] [Full Text] [Related]

  • 14. Double-blind, placebo-substitution study of nefazodone in the prevention of relapse during continuation treatment of outpatients with major depression.
    Feiger AD, Bielski RJ, Bremner J, Heiser JF, Trivedi M, Wilcox CS, Roberts DL, Kensler TT, McQuade RD, Kaplita SB, Archibald DG.
    Int Clin Psychopharmacol; 1999 Jan; 14(1):19-28. PubMed ID: 10221638
    [Abstract] [Full Text] [Related]

  • 15. Nefazodone treatment of major depression in alcohol-dependent patients: a double-blind, placebo-controlled trial.
    Roy-Byrne PP, Pages KP, Russo JE, Jaffe C, Blume AW, Kingsley E, Cowley DS, Ries RK.
    J Clin Psychopharmacol; 2000 Apr; 20(2):129-36. PubMed ID: 10770449
    [Abstract] [Full Text] [Related]

  • 16. A double-blind, placebo-controlled trial of two dose ranges of nefazodone in the treatment of depressed outpatients.
    Mendels J, Reimherr F, Marcus RN, Roberts DL, Francis RJ, Anton SF.
    J Clin Psychiatry; 1995 Apr; 56 Suppl 6():30-6. PubMed ID: 7649971
    [Abstract] [Full Text] [Related]

  • 17. Randomized, placebo-controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depression.
    Gelenberg AJ, Trivedi MH, Rush AJ, Thase ME, Howland R, Klein DN, Kornstein SG, Dunner DL, Markowitz JC, Hirschfeld RM, Keitner GI, Zajecka J, Kocsis JH, Russell JM, Miller I, Manber R, Arnow B, Rothbaum B, Munsaka M, Banks P, Borian FE, Keller MB.
    Biol Psychiatry; 2003 Oct 15; 54(8):806-17. PubMed ID: 14550680
    [Abstract] [Full Text] [Related]

  • 18. Multicenter, placebo-controlled, fixed-dose study of citalopram in moderate-to-severe depression.
    Feighner JP, Overø K.
    J Clin Psychiatry; 1999 Dec 15; 60(12):824-30. PubMed ID: 10665628
    [Abstract] [Full Text] [Related]

  • 19. Nefazodone: aspects of efficacy.
    Rickels K, Robinson DS, Schweizer E, Marcus RN, Roberts DL.
    J Clin Psychiatry; 1995 Dec 15; 56 Suppl 6():43-6. PubMed ID: 7649973
    [Abstract] [Full Text] [Related]

  • 20. Treatment of major depression in HIV-seropositive men. HIV Neurobehavioral Research Center Group.
    Zisook S, Peterkin J, Goggin KJ, Sledge P, Atkinson JH, Grant I.
    J Clin Psychiatry; 1998 May 15; 59(5):217-24. PubMed ID: 9632030
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.